

Celfavor® MNMH
Reduced Nicotinamide Mononucleotide
Core Product Advantages
- As the reduced form of NMN and a highly efficient precursor of NAD+, NMNH can directly increase cellular NAD+ and NADH levels, effectively activate mitochondria, repair DNA, exert anti-inflammatory and antioxidant effects, protect organs, and improve metabolism. This results in rapid anti-fatigue effects, biological age reversal and anti-aging benefits.
- Celfavor® NMNH uses microsphere encapsulation technology to stabilize activity, solving the problems of easy degradation, gastric acid decomposition and poor absorption of NMNH, and is more efficient than NMN and NR in boosting NAD+ levels, with remarkable metabolic activation and anti-aging effects.
Limitations of Conventional NMNH
Core Product Advantages
Unstable
Ordinary NMNH has highly unstable chemical properties and is easily oxidized and degraded by light, temperature, humidity, air contact and gastric acid, greatly limiting its wide application.
High stability
Celfavor's patented microsphere technology significantly improves the stability of active ingredients, enabling storage for 36 months at room temperature in the dark without degradation in gastric acid.
Extremely low bioavailability
Easily degraded during room-temperature storage and in the gastric acid environment, unable to reach the intestinal tract for absorption.
High bioavailability
100% stable retention in the stomach, targeted intestinal release; sustained release in the intestine, greatly improving absorption efficiency.
Stable compounding
Suitable for hard capsules, can be compounded with other ingredients
Basic Product Information
| Item | Details |
|---|---|
| Appearance | Light yellow microspheres (color customizable upon request) |
| NADH content | 10% |
| Dosage form | Capsule |
| Recommended dosage | 10–20 mg/day (based on NMNH content) |
Core Efficacies
Experimental Data

Excellent Stability Under Digestion in Simulated Gastric Acid with pH 2.0

Excellent Stability Under Accelerated Conditions (37℃, 75% Humidity)
Male C57BL/6 mice weighing 20 g were randomly assigned to four groups and administered intragastrically with normal saline, NMN, NMNH, and Celfavor NMNH at a dose of 250 mg/kg, respectively. Blood samples were collected from the lateral saphenous vein at 2, 4, and 20 hours after the first intragastric administration. Another intragastric dose was given 20 hours later. Four hours after the second administration, the mice were sacrificed under isoflurane anesthesia. Blood and renal tubular epithelial cells were collected and immediately snap-frozen in liquid nitrogen.

Efficiency of Celfavor® NMNH in Increasing NAD+

Improve mitochondrial function (up-regulate the expression of mitochondrial transcription factor Tfam)